Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 30% ± 12% | |
lung | 10 studies | 27% ± 12% | |
intestine | 8 studies | 32% ± 15% | |
kidney | 7 studies | 29% ± 9% | |
eye | 7 studies | 32% ± 12% | |
breast | 4 studies | 23% ± 2% | |
liver | 4 studies | 25% ± 5% | |
pancreas | 3 studies | 44% ± 10% | |
uterus | 3 studies | 44% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 8926.63 | 459 / 459 | 100% | 314.52 | 1117 / 1118 |
prostate | 100% | 7514.08 | 245 / 245 | 100% | 220.26 | 501 / 502 |
uterus | 100% | 7796.69 | 170 / 170 | 100% | 289.02 | 458 / 459 |
stomach | 100% | 4481.64 | 359 / 359 | 100% | 260.64 | 285 / 286 |
ovary | 100% | 6217.08 | 180 / 180 | 100% | 271.83 | 428 / 430 |
brain | 100% | 8441.40 | 2632 / 2642 | 100% | 281.65 | 704 / 705 |
esophagus | 100% | 5100.90 | 1445 / 1445 | 99% | 197.63 | 182 / 183 |
kidney | 100% | 6909.35 | 89 / 89 | 99% | 419.87 | 896 / 901 |
intestine | 100% | 6956.22 | 966 / 966 | 99% | 285.39 | 524 / 527 |
bladder | 100% | 6824.48 | 21 / 21 | 99% | 270.42 | 501 / 504 |
lung | 99% | 5064.29 | 574 / 578 | 100% | 249.40 | 1155 / 1155 |
adrenal gland | 100% | 14669.38 | 258 / 258 | 99% | 441.41 | 228 / 230 |
liver | 100% | 14348.00 | 226 / 226 | 99% | 526.09 | 402 / 406 |
thymus | 100% | 5608.60 | 652 / 653 | 99% | 267.20 | 597 / 605 |
skin | 100% | 5910.67 | 1801 / 1809 | 92% | 164.48 | 432 / 472 |
pancreas | 88% | 1824.17 | 289 / 328 | 98% | 200.77 | 175 / 178 |
adipose | 100% | 8509.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 181.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 118.21 | 1 / 1 |
blood vessel | 100% | 7476.30 | 1333 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 2659.24 | 237 / 241 | 0% | 0 | 0 / 0 |
heart | 74% | 1677.97 | 639 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 65.36 | 50 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 41.29 | 17 / 29 |
peripheral blood | 46% | 966.94 | 423 / 929 | 0% | 0 | 0 / 0 |
muscle | 17% | 283.24 | 133 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006783 | Biological process | heme biosynthetic process |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0140077 | Biological process | positive regulation of lipoprotein transport |
GO_0005576 | Cellular component | extracellular region |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0016020 | Cellular component | membrane |
GO_0043025 | Cellular component | neuronal cell body |
GO_0043005 | Cellular component | neuron projection |
GO_0030868 | Cellular component | smooth endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0045202 | Cellular component | synapse |
GO_0044297 | Cellular component | cell body |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0020037 | Molecular function | heme binding |
GO_0005496 | Molecular function | steroid binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PGRMC1 |
Protein name | Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA) Membrane-associated progesterone receptor component 1 |
Synonyms | hCG_23188 HPR6.6 PGRMC |
Description | FUNCTION: Component of a progesterone-binding protein complex . Binds progesterone . Has many reported cellular functions (heme homeostasis, interaction with CYPs). Required for the maintenance of uterine histoarchitecture and normal female reproductive lifespan (By similarity). Intracellular heme chaperone. Regulates heme synthesis via interactions with FECH and acts as a heme donor for at least some hemoproteins . Forms a ternary complex with TMEM97 receptor and low density lipid receptor/LDLR, which increases LDLR-mediated LDL lipoprotein internalization . . |
Accessions | O00264 ENST00000535419.2 [O00264-2] Q6IB11 ENST00000217971.8 [O00264-1] |